Antibiotic OS-3256-B

Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

195 80R, A61K 3574

Patent

active

039950280

ABSTRACT:
The present invention relates to a new antibiotic designated as OS-3256-B. OS-3256-B exhibits excellent inhibitory activities against animal tumors such as leukemia L-1210, Sarcoma-180 and Hela cells and gram-positive bacteria and is classified into the diazocompounds group. However, chromatographic analysis, Rf value and other experimental data reveal that OS-3256-B is a new compound of the type of azaamino acid derivatives. The present invention also provides a process for producing OS-3256-B by fermentation, in which OS-3256-B is produced by culturing a microorganism belonging to Streptomyces candidus var. azaticus in a culture medium conventionally used for culturing Streptomyces strain microorganisms.

REFERENCES:
derwent Farmpol No. 70217v 40, Abstracting JA 095234, Published May 15, 1974.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibiotic OS-3256-B does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibiotic OS-3256-B, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic OS-3256-B will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1055623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.